- A Cancer Trial for All of Us | February 25, 2021
- It Doesn’t Matter Whether It’s COVID or Cancer: We Need to Unite All to Cure the One | KevinMD.com | May 14, 2020
- Moving Cancer Towards a Cure | April 23, 2020
- Snapshot: Trial Types in Precision Medicine | CELL | April 2, 2020
- Taproot Health, Five Cancer Centers Agree to Conduct Precision Oncology Master Trial, Share Data | GenomeWeb | January 13, 2020
- The Master Observational Trial: A New Class of Master Protocol to Advance Precision Medicine | CELL | January 9, 2020
- Taproot Health Names Lori Miles as Director of Clinical Operations | February 1, 2021
- Taproot Health Names Guy Fordham as Senior Vice President of Finance | January 13, 2021
- Taproot Health, Inc. Names Dan Weaver as Chief Technology and Information Officer | November 12, 2020
- Taproot Health™ Expands First-of-Its-Kind Oncology Database and Research Marketplace | May 22, 2020
- Taproot Health Launches National Oncology Master Trial and Research Database Five Cornerstone Centers Join Effort | January 2, 2020
- Taproot Health, Five Cancer Centers Agree to Conduct Precision Oncology Master Trial, Share Data | January 2, 2020
- Taproot Health Launches National Oncology Master Trial and Research Database | January 2, 2020
It is common knowledge that smoking is bad for your health. Many are familiar with the fact that smoking cigarettes increases the risk of heart disease, stroke, and lung cancer…
What do we need to develop a stepwise approach to advancing precision medicine? Why is data so important? Check out a preview of Taproot’s founder and CEO Dane Dickson, MD podcast interview here and...
The 2020 JP Morgan Healthcare conference is in the books and what an amazing experience it was for the Taproot Health team. The connections we’ve made, the encouragement we’ve received, the interest that has been expressed – all has been very positive. We could not be more pleased with what we experienced over those few days.
Monday morning, the 11:00 a.m. new patient slot which is always filled. This time it was a man named Jay in his mid-60s. He had just retired and was looking forward to pursuing his two great...